Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
BACKGROUND: Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document providing recommendations for the use of SYSADOA in osteoarthritis (OA). METHODS: The following interventions were taken into consideration: avocad...
Main Authors: | Bruyere, Olivier (Author), Burlet, Nansa (Author), Delmas, Pierre D. (Author), Rizzoli, René (Author), Cooper, Cyrus (Author), Reginster, Jean-Yves (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2008.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
by: Rizzoli René, et al.
Published: (2008-12-01) -
SYMPTOMATIC SLOW ACTING DRUGS IN THE TREATMENT OF OSTEOARTHRITIS
by: L. I. Alekseeva
Published: (2012-04-01) -
Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01) -
Pharmacological treatment options for osteoarthritis: focus on symptomatic slow-acting drugs for osteoarthritis (SYSADOA) and individual patient characteristics: Resolution of the International Expert Meeting
by: A. M. Lila, et al.
Published: (2019-10-01) -
European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Newsletter
by: RENE RIZZOLI, et al.
Published: (2007-08-01)